Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations

por Otten, Thomas Michael, Grimm, Sabine E., Ramaekers, Bram, Joore, Manuela A.
Publicado 2023

Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models

por Grimm, Sabine E., Pouwels, Xavier, Ramaekers, Bram L. T., Wijnen, Ben, Knies, Saskia, Grutters, Janneke, Joore, Manuela A.
Publicado 2019

Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence genera...

por Grimm, Sabine E., Pouwels, Xavier, Ramaekers, Bram L. T., Wijnen, Ben, Knies, Saskia, Grutters, Janneke, Joore, Manuela A.
Publicado 2021

Correction to: Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the...

por Grimm, Sabine E., Pouwels, Xavier, Ramaekers, Bram L. T., Wijnen, Ben, Knies, Saskia, Grutters, Janneke, Joore, Manuela A.
Publicado 2021

State of the ART? Two New Tools for Risk Communication in Health Technology Assessments

por Grimm, Sabine E., Pouwels, Xavier, Ramaekers, Bram L. T., Wijnen, Ben, Otten, Thomas, Grutters, Janneke, Joore, Manuela A.
Publicado 2021

Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Grimm, Sabine E., Wijnen, Ben, Riemsma, Rob, Fayter, Debra, Armstrong, Nigel, Ahmadu, Charlotte, Brandts, Lloyd, Misso, Kate, Kirwan, John R., Kleijnen, Jos, Joore, Manuela A.
Publicado 2021

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Grimm, Sabine E., Fayter, Debra, Ramaekers, Bram L. T., Petersohn, Svenja, Riemsma, Rob, Armstrong, Nigel, Pouwels, Xavier, Witlox, Willem, Noake, Caro, Worthy, Gillian, Kleijnen, Jos, Joore, Manuela A.
Publicado 2019

Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Grimm, Sabine E., Witlox, Willem, Wolff, Robert, Chalker, Annette, Hiligsmann, Mickael, Wijnen, Ben, Ahmadu, Charlotte, Ryder, Steve, Armstrong, Nigel, Duffy, Steven, Syndikus, Isabel, Kleijnen, Jos, Joore, Manuela A.
Publicado 2022

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Grimm, Sabine E., Witlox, Willem, Wolff, Robert, Chalker, Annette, Hiligsmann, Mickael, Wijnen, Ben, Ahmadu, Charlotte, Ryder, Steve, Armstrong, Nigel, Duffy, Steven, Syndikus, Isabel, Kleijnen, Jos, Joore, Manuela A.
Publicado 2021

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Witlox, Willem J. A., van Asselt, Antoinette D. I., Wolff, Robert, Armstrong, Nigel, Worthy, Gill, Chalker, Annette, Buksnys, Titas, Stirk, Lisa, Kleijnen, Jos, Joore, Manuela A., Grimm, Sabine E.
Publicado 2019

Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por van Asselt, Antoinette D. I., Armstrong, Nigel, Kimman, Merel, Peeters, Andrea, McDermott, Kevin, Stirk, Lisa, Ahmadu, Charlotte, Govers, Tim M., Hoentjen, Frank, Joore, Manuela A., Grimm, Sabine E.
Publicado 2023

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

por Witlox, Willem J. A., Grimm, Sabine E., Riemsma, Rob, Armstrong, Nigel, Ryder, Steve, Duffy, Steven, Carrera, Vanesa Huertas, Posadzki, Pawel, Worthy, Gillian, Pouwels, Xavier G. L. V., Ramaekers, Bram L. T., Kleijnen, Jos, Joore, Manuela A., van Asselt, Antoinette D. I.
Publicado 2020